Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome

European Respiratory Journal

Volumn 13, Issue 5, 1999, Pages 1029-1036

  Sallenave, J M ^a   Donnelly, S C ^a   Grant, I S ^b   Robertson, C ^c   Gauldie, J ^d   Haslett, C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Acute respiratory distress syndrome; Alpha 1 proteinase inhibitor; Antiproteinase; Elafin; Inflammation; Secretory leukocyte proteinase inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELAFIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; LUNG LAVAGE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ALPHA 1-ANTITRYPSIN; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; LEUKOCYTE ELASTASE; MEMBRANE PROTEINS; MIDDLE AGED; PROTEASE INHIBITORS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RESPIRATORY DISTRESS SYNDROME, ADULT; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS;

EID: 0033037431     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13e16.x     Document Type: Article

References (31)

1. Lee CT, Fein AM, Lippman M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory syndrome. N Engl J Med 1981; 304: 192-196.
2. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 (IL-8) and the development of the adult respiratory distress syndrome (ARDS). Lancet 1993; 341: 643-647.
3. Miller EJ, Nagao S, Cohen AB, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427-432.
4. McGuirre WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 1981; 69: 543-553.
5. Christner P, Fein A, Goldberg S, Lippman M, Abrams W, Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Dis 1985; 131: 690-695.
6. Weiland JE, Davis WB, Holler JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Am Rev Respir Dis 1986; 133: 218-225.
7. Laurell CB, Ericksson S. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-140.
8. Heinzel R, Appelhans RH, Gassen HG, et al. Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur J Biochem 1986; 160: 61-67.
9. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E. Elafin, an elastase-specific inhibitor from human skin. J Biol Chem 1990; 265: 14791-14795.
10. Sallenave J-M, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler 1991; 372: 13-21.
11. Sallenave J-M, Silva A. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am J Respir Cell Mol Biol 1993; 8: 439-445.
12. Stockley RA, Morrisson HM, Smith S, Tetley T. Low molecular mass bronchial proteinase inhibitor and alpha-1 proteinase inhibitor in sputum and bronchoalveolar lavage. Physiol Chem Hoppe Seyler 1984; 365: 587-595.
13. Willems LNA, Kramps JA, Stijnen T, Sterk PJ, Weening JJ, Dijkman JH. Antileukoprotease-containing bronchiolar cells. Relationship with morphologic disease of small airways and parenchyma. Am Rev Respir Dis 1989; 139: 1244-1250.
14. Smith SF, Guz A, Cooke NT, Burton GH, Tetley TD. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin Sci 1985; 69: 17-27.
15. Trembloy G, Sallenave J-M, Israel-Assayag E, Cormier Y, Gauldie J. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Am J Respir Crit Care Med 1996; 154: 1092-1098.
16. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
17. Donnelly SC, Haslett C, Dransfield I, et al. Role of selectins in development of adult respiratory distress syndrome. Lancet 1994; 344: 215-219.
18. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS) - a prospective study. J Am Med Assoc 1995; 11: 117-123.
19. Sallenave J-M, Schulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelium cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11: 733-741.
20. Bieth JG. Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull Eur Physiopath Respir 1980; 16: Suppl., 183-195.
21. Idell S, Kucich U, Fein A, et al. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 1098-1105.
22. Wewers MD, Herzyk DJ, Gadek JE. Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J Clin Invest 1988; 82: 1260-1267.
23. Sallenave J-M, Si-Tahar M, Cox G, Chignard M, Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 1997; 61: 695-702.
24. Venembre P, Boutteu A, Seta N, et al. Secretion of alpha-1 antitrypsin by alveolar epithelial cells. FEBS Lett 1994; 346: 171-174.
25. Sallenave J-M, Tremblay GM, Gauldie J, Richards C. Oncostatin M, but not interleukin-6 or leukaemia inhibitory factor, stimulates expression of alpha-1 proteinase inhibitor in A549 human alveolar epithelial cells. J Interf Cytok Res 1997; 17: 337-346.
26. Maunder RJ, Chaney BA, Cokrill DL, Allen KB, Romaneschi LD, Hudson LD. Protease-antiprotease balance favors elastase inhibitors in bronchoalveolar lavage fluid of ARDS patients. Am Rev Respir Dis 1991; 141: A150.
27. Boudier C, Carvallo D, Roitsh C, Bieth J, Courtney M. Purification and characterization of human bronchial proteinase inhibitor. Arch Biochem Biophys 1987; 253: 439-445.
28. Goldstein W, Doring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis 1985; 134: 49-56.
29. Birrer P, McElvaney NG, Rudeberg A, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994; 150: 207-213.
30. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154: 346-352.
31. Torii K, Iida K-I, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 43-46.